Ad
related to: meningococcal meningitis structure and drug resistance treatment guidelines- View Meningitis Vaccines
Learn More About Vaccines And
Explore The Meningitis Portfolio
- Company And Products
View Resources & Product Portfolio
For GSK
- GSK Meningitis Portfolio
Explore GSK Meningitis Vaccines And
Learn About The Vaccine Portfolio
- Meningitis Portfolio
View Resources & Product Portfolio
Learn About The Vaccine Portfolio
- View Meningitis Vaccines
Search results
Results From The WOW.Com Content Network
In cases of meningococcal meningitis, preventative treatment in close contacts with antibiotics (e.g. rifampicin, ciprofloxacin or ceftriaxone) can reduce their risk of contracting the condition, but does not protect against future infections. [48] [69] Resistance to rifampicin has been noted to increase after use, which has caused some to ...
In June 2012, the U.S. Food and Drug Administration (FDA) approved a combination vaccine against two types of meningococcal diseases and Hib disease for infants and children 6 weeks to 18 months old. The vaccine, Menhibrix , was designed to prevent disease caused by Neisseria meningitidis serogroups C and Y, and Haemophilus influenzae type b (Hib).
Meningococcal meningitis is a form of bacterial meningitis. Meningitis is a disease caused by inflammation and irritation of the meninges , the membranes surrounding the brain and spinal cord. In meningococcal meningitis this is caused by the bacteria invading the cerebrospinal fluid and circulating through the central nervous system .
N. meningitidis (also called the meningococcus) is one of the most common causes of bacterial meningitis and the causative agent of meningococcal septicaemia. The immune system's neutrophils are restricted in function due to the ability of Neisseria to evade opsonization by antibodies, and to replicate within neutrophils despite phagocytosis.
There is a paucity of information regarding the optimal treatment regiment for multi-drug resistant tuberculosis meningitis (which is by definition resistant to isoniazid and rifampin), but fluoroquinolones and aminoglycosides can achieve adequate brain and spinal cord penetration and are often used. [4]
The first-of-its-kind shot addresses the five most common causes of meningococcal disease, Pfizer says. Vaccine aimed at preventing meningitis in kids approved by FDA. What happens next?
The charity Meningitis Now also called on members of the public to educate themselves on the signs and symptoms of the illness, and to “act swiftly” if meningitis is suspected.
Fulminant infection from meningococcal bacteria in the bloodstream is a medical emergency and requires emergent treatment with vasopressors, fluid resuscitation, and appropriate antibiotics. Benzylpenicillin was once the drug of choice with chloramphenicol as a good alternative in allergic patients. Ceftriaxone is an antibiotic commonly ...
Ad
related to: meningococcal meningitis structure and drug resistance treatment guidelines